3-196296136-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_152773.5(DYNLT2B):c.318-67G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0654 in 1,323,530 control chromosomes in the GnomAD database, including 3,369 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.065 ( 380 hom., cov: 32)
Exomes 𝑓: 0.065 ( 2989 hom. )
Consequence
DYNLT2B
NM_152773.5 intron
NM_152773.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.37
Genes affected
DYNLT2B (HGNC:28482): (dynein light chain Tctex-type 2B) Dyneins are a group of microtubule-activated ATPases that function as molecular motors. They are divided into two subgroups of axonemal and cytoplasmic dyneins. The cytoplasmic dyneins function in intracellular motility, including retrograde axonal transport, protein sorting, organelle movement, and spindle dynamics. Molecules of conventional cytoplasmic dynein are comprised of 2 heavy chain polypeptides and a number of intermediate and light chains. This gene encodes a subunit of the human cytoplasmic dynein-2 complex. Mutations in this gene are associated with short-rib thoracic dysplasia 17 with or without polydactyly. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 3-196296136-C-T is Benign according to our data. Variant chr3-196296136-C-T is described in ClinVar as [Benign]. Clinvar id is 1262426.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0654 AC: 9956AN: 152134Hom.: 379 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9956
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0653 AC: 76540AN: 1171278Hom.: 2989 Cov.: 16 AF XY: 0.0682 AC XY: 40655AN XY: 596286 show subpopulations
GnomAD4 exome
AF:
AC:
76540
AN:
1171278
Hom.:
Cov.:
16
AF XY:
AC XY:
40655
AN XY:
596286
Gnomad4 AFR exome
AF:
AC:
2057
AN:
27578
Gnomad4 AMR exome
AF:
AC:
1471
AN:
43756
Gnomad4 ASJ exome
AF:
AC:
2709
AN:
24184
Gnomad4 EAS exome
AF:
AC:
650
AN:
38248
Gnomad4 SAS exome
AF:
AC:
9657
AN:
79844
Gnomad4 FIN exome
AF:
AC:
2142
AN:
53052
Gnomad4 NFE exome
AF:
AC:
53495
AN:
848668
Gnomad4 Remaining exome
AF:
AC:
3714
AN:
50754
Heterozygous variant carriers
0
3375
6750
10126
13501
16876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1736
3472
5208
6944
8680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0654 AC: 9960AN: 152252Hom.: 380 Cov.: 32 AF XY: 0.0659 AC XY: 4902AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
9960
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
4902
AN XY:
74434
Gnomad4 AFR
AF:
AC:
0.0759603
AN:
0.0759603
Gnomad4 AMR
AF:
AC:
0.044581
AN:
0.044581
Gnomad4 ASJ
AF:
AC:
0.111527
AN:
0.111527
Gnomad4 EAS
AF:
AC:
0.0167436
AN:
0.0167436
Gnomad4 SAS
AF:
AC:
0.123288
AN:
0.123288
Gnomad4 FIN
AF:
AC:
0.0371909
AN:
0.0371909
Gnomad4 NFE
AF:
AC:
0.0647827
AN:
0.0647827
Gnomad4 OTH
AF:
AC:
0.0604915
AN:
0.0604915
Heterozygous variant carriers
0
494
987
1481
1974
2468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
217
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at